{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:55:20Z","timestamp":1789905320378,"version":"4.0.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This project was funded by the U.S. Food and Drug Administration and, in part, by a Cooperative Research and Development Agreement with Emulate, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The pathology of Alzheimer\u2019s Disease (AD) is characterized by aggregates of amyloid beta (A\u03b2) peptides and neurofibrillary tau tangles. Increased blood-brain barrier (BBB) permeability and reduced A\u03b2 clearance, which signal neurovascular dysfunction, have also been proposed as early markers of AD. Despite intense scrutiny, the mechanisms of AD remain elusive and novel treatments that address core symptoms of dementia are limited. New alternative methods (NAMs) aim to develop in-vitro translational models that recapitulate human pathology more accurately than previous models and could contribute to the development of new therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we developed a NAM model of the cortical neurovascular unit (NVU) using brain cells derived from human induced pluripotent stem cells (hiPSCs) from a patient with AD and a healthy individual. Differentiated neurons, astrocytes, pericytes, microglia, and brain-like microvascular endothelial cells were cultured in a microphysiological system to create a brain-chip model to evaluate NVU-related endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to control, AD brain-chips had reduced claudin-5 and ZO-1 expression and increased paracellular permeability. AD brain-chips also had decreased activity of the efflux transporter P-glycoprotein (P-gp), but its expression was unchanged. In AD brain-chips, levels of A\u03b242, total tau, and p-tau 181 were decreased in protein lysates from the brain channel, while levels of total tau and p-tau 181 were increased in protein lysates from the vascular channel. Finally, AD brain-chips had increased levels of the proinflammatory markers IL-6 and MCP-1 in effluent from both brain and vascular channels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this brain-chip model, we showed A\u03b2-independent NVU dysfunction that was related to neuroinflammation and vascular tau accumulation. This study demonstrates the utility of the brain-chip model to evaluate changes in NVU functions induced by AD-like pathology and highlights donor-specific responses associated with the use of hiPSC-derived models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00708-y","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:59:11Z","timestamp":1767704351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modeling neurovascular dysfunction in Alzheimer\u2019s disease using an isogenic brain-chip model"],"prefix":"10.1186","volume":"23","author":[{"given":"Andrew N.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelin S.","family":"Matazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Drew","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Ewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"Daughters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Rosas-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"1","key":"708_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77(1):32\u201342.","journal-title":"Mt Sinai J Med"},{"issue":"3","key":"708_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133\u201350.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"708_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"708_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"4","key":"708_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/brain\/awz011","volume":"142","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Shinohara M, Shinohara M, Yamazaki A, Murray ME, Liesinger AM, et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer\u2019s disease progression. Brain. 2019;142(4):1077\u201392.","journal-title":"Brain"},{"issue":"5","key":"708_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00401-019-01967-4","volume":"137","author":"P Bourassa","year":"2019","unstructured":"Bourassa P, Tremblay C, Schneider JA, Bennett DA, Calon F. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer\u2019s disease. Acta Neuropathol. 2019;137(5):801\u201323.","journal-title":"Acta Neuropathol"},{"issue":"Pt 1","key":"708_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/brain\/awr298","volume":"135","author":"DM van Assema","year":"2012","unstructured":"van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, et al. Blood-brain barrier P-glycoprotein function in alzheimer\u2019s disease. Brain. 2012;135(Pt 1):181\u20139.","journal-title":"Brain"},{"issue":"7","key":"708_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-020-0065-9","volume":"19","author":"K Scearce-Levie","year":"2020","unstructured":"Scearce-Levie K, Sanchez PE, Lewcock JW. Leveraging preclinical models for the development of Alzheimer disease therapeutics. Nat Rev Drug Discov. 2020;19(7):447\u201362.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"708_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137\u201352.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"708_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-170045","volume":"57","author":"G Esquerda-Canals","year":"2017","unstructured":"Esquerda-Canals G, Montoliu-Gaya L, Guell-Bosch J, Villegas S. Mouse models of alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1171\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"708_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol. 2017;133(2):155\u201375.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"708_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"708_CR13","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1038\/s41380-024-02565-x","volume":"29","author":"Z Qian","year":"2024","unstructured":"Qian Z, Wang Z, Li B, Meng X, Kuang Z, Li Y, et al. Thy1-ApoE4\/C\/EBPbeta double Transgenic mice act as a sporadic model with alzheimer\u2019s disease. Mol Psychiatry. 2024;29(10):3040\u201355.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"708_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/17460441.2018.1398730","volume":"13","author":"B Guo","year":"2018","unstructured":"Guo B, Zhou Q. How efficient are rodent models for Alzheimer\u2019s disease drug discovery? Expert Opin Drug Discov. 2018;13(2):113\u20135.","journal-title":"Expert Opin Drug Discov"},{"key":"708_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.conb.2020.01.008","volume":"61","author":"J Klimmt","year":"2020","unstructured":"Klimmt J, Dannert A, Paquet D. Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer\u2019s disease. Curr Opin Neurobiol. 2020;61:96\u2013104.","journal-title":"Curr Opin Neurobiol"},{"issue":"23","key":"708_CR16","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, et al. Modeling familial alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20(23):4530\u20139.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"708_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"5","key":"708_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78(5):785\u201398.","journal-title":"Neuron"},{"issue":"3","key":"708_CR19","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1038\/cddis.2017.89","volume":"8","author":"VC Jones","year":"2017","unstructured":"Jones VC, Atkinson-Dell R, Verkhratsky A, Mohamet L. Aberrant iPSC-derived human astrocytes in alzheimer\u2019s disease. Cell Death Dis. 2017;8(3):e2696.","journal-title":"Cell Death Dis"},{"issue":"6","key":"708_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.neuron.2018.06.011","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98(6):1294.","journal-title":"Neuron"},{"issue":"6","key":"708_CR21","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","volume":"9","author":"M Oksanen","year":"2017","unstructured":"Oksanen M, Petersen AJ, Naumenko N, Puttonen K, Lehtonen S, Gubert Olive M, et al. PSEN1 mutant iPSC-Derived model reveals severe astrocyte pathology in alzheimer\u2019s disease. Stem Cell Rep. 2017;9(6):1885\u201397.","journal-title":"Stem Cell Rep"},{"issue":"14","key":"708_CR22","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao J, Davis MD, Martens YA, Shinohara M, Graff-Radford NR, Younkin SG, et al. APOE epsilon4\/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet. 2017;26(14):2690\u2013700.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"708_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, et al. iPSC-Derived human Microglia-like cells to study neurological diseases. Neuron. 2017;94(2):278\u201393. e9.","journal-title":"Neuron"},{"issue":"1","key":"708_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12987-024-00576-y","volume":"21","author":"YC Wu","year":"2024","unstructured":"Wu YC, Lehtonen S, Trontti K, Kauppinen R, Kettunen P, Leinonen V, et al. Human iPSC-derived pericyte-like cells carrying APP Swedish mutation overproduce beta-amyloid and induce cerebral amyloid angiopathy-like changes. Fluids Barriers CNS. 2024;21(1):78.","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"708_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1701679","volume":"3","author":"T Qian","year":"2017","unstructured":"Qian T, Maguire SE, Canfield SG, Bao X, Olson WR, Shusta EV, et al. Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells. Sci Adv. 2017;3(11):e1701679.","journal-title":"Sci Adv"},{"issue":"6","key":"708_CR26","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1007\/s12035-018-1336-x","volume":"56","author":"KH Chang","year":"2019","unstructured":"Chang KH, Lee-Chen GJ, Huang CC, Lin JL, Chen YJ, Wei PC, et al. Modeling Alzheimer\u2019s disease by induced pluripotent stem cells carrying APP D678H mutation. Mol Neurobiol. 2019;56(6):3972\u201383.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"708_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","volume":"104","author":"D Kwart","year":"2019","unstructured":"Kwart D, Gregg A, Scheckel C, Murphy EA, Paquet D, Duffield M, et al. A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP beta-CTFs, not Abeta. Neuron. 2019;104(2):256\u201370. e5.","journal-title":"Neuron"},{"issue":"24","key":"708_CR28","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1089\/scd.2013.0511","volume":"23","author":"V Mahairaki","year":"2014","unstructured":"Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, et al. Induced pluripotent stem cells from Familial Alzheimer\u2019s disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells Dev. 2014;23(24):2996\u20133010.","journal-title":"Stem Cells Dev"},{"issue":"189","key":"708_CR29","doi-asserted-by":"publisher","first-page":"189ra77","DOI":"10.1126\/scitranslmed.3005615","volume":"5","author":"R Potter","year":"2013","unstructured":"Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, et al. Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med. 2013;5(189):189ra77.","journal-title":"Sci Transl Med"},{"issue":"3","key":"708_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031030","volume":"21","author":"S Schrank","year":"2020","unstructured":"Schrank S, McDaid J, Briggs CA, Mustaly-Kalimi S, Brinks D, Houcek A, et al. Human-induced neurons from Presenilin 1 mutant patients model aspects of Alzheimer\u2019s disease pathology. Int J Mol Sci. 2020;21(3):1030.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"708_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac267","volume":"4","author":"B Ng","year":"2022","unstructured":"Ng B, Rowland HA, Wei T, Arunasalam K, Hayes EM, Koychev I, et al. Neurons derived from individual early Alzheimer\u2019s disease patients reflect their clinical vulnerability. Brain Commun. 2022;4(6):fcac267.","journal-title":"Brain Commun"},{"issue":"4","key":"708_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","volume":"13","author":"H Konttinen","year":"2019","unstructured":"Konttinen H, Cabral-da-Silva MEC, Ohtonen S, Wojciechowski S, Shakirzyanova A, Caligola S, et al. PSEN1DeltaE9, appswe, and APOE4 confer disparate phenotypes in human iPSC-Derived microglia. Stem Cell Rep. 2019;13(4):669\u201383.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"708_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12974-023-02951-2","volume":"21","author":"MA Sullivan","year":"2024","unstructured":"Sullivan MA, Lane SD, McKenzie ADJ, Ball SR, Sunde M, Neely GG, et al. iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype. J Neuroinflammation. 2024;21(1):7.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"708_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12987-024-00580-2","volume":"21","author":"Y Ding","year":"2024","unstructured":"Ding Y, Palecek SP, Shusta EV. Ipsc-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta. Fluids Barriers CNS. 2024;21(1):79.","journal-title":"Fluids Barriers CNS"},{"key":"708_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2020.03.011","author":"LE Oikari","year":"2020","unstructured":"Oikari LE, Pandit R, Stewart R, Cuni-Lopez C, Quek H, Sutharsan R, et al. Altered brain endothelial cell phenotype from a familial Alzheimer mutation and its potential implications for amyloid clearance and drug delivery. Stem Cell Reports. 2020. https:\/\/doi.org\/10.1016\/j.stemcr.2020.03.011.","journal-title":"Stem Cell Reports"},{"issue":"6","key":"708_CR36","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","volume":"26","author":"JW Blanchard","year":"2020","unstructured":"Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, et al. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26(6):952\u201363.","journal-title":"Nat Med"},{"issue":"4","key":"708_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrd4539","volume":"14","author":"EW Esch","year":"2015","unstructured":"Esch EW, Bahinski A, Huh D. Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov. 2015;14(4):248\u201360.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"708_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cell.2016.02.049","volume":"164","author":"DE Ingber","year":"2016","unstructured":"Ingber DE. Reverse engineering human pathophysiology with Organs-on-chips. Cell. 2016;164(6):1105\u20139.","journal-title":"Cell"},{"key":"708_CR39","doi-asserted-by":"publisher","DOI":"10.1242\/dev.156125","author":"DE Ingber","year":"2018","unstructured":"Ingber DE. Developmentally inspired human \u2018organs on chips.\u2019 Development. 2018. https:\/\/doi.org\/10.1242\/dev.156125.","journal-title":"Development"},{"issue":"1","key":"708_CR40","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41467-019-10588-0","volume":"10","author":"TE Park","year":"2019","unstructured":"Park TE, Mustafaoglu N, Herland A, Hasselkus R, Mannix R, FitzGerald EA, et al. Hypoxia-enhanced blood-brain barrier chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat Commun. 2019;10(1):2621.","journal-title":"Nat Commun"},{"key":"708_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fbioe.2019.00100","volume":"7","author":"JP Frimat","year":"2019","unstructured":"Frimat JP, Luttge R. The need for physiological micro-nanofluidic systems of the brain. Front Bioeng Biotechnol. 2019;7:100.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"708_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nbt.4226","volume":"36","author":"BM Maoz","year":"2018","unstructured":"Maoz BM, Herland A, FitzGerald EA, Grevesse T, Vidoudez C, Pacheco AR, et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells. Nat Biotechnol. 2018;36(9):865\u201374.","journal-title":"Nat Biotechnol"},{"key":"708_CR43","doi-asserted-by":"crossref","unstructured":"Jagadeesan S, Workman MJ, Herland A, Svendsen CN, Vatine GD. Generation of a human iPSC-based blood-brain barrier chip. J Vis Exp. 2020;157.","DOI":"10.3791\/60925-v"},{"issue":"6","key":"708_CR44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.stem.2019.05.011","volume":"24","author":"GD Vatine","year":"2019","unstructured":"Vatine GD, Barrile R, Workman MJ, Sances S, Barriga BK, Rahnama M, et al. Human iPSC-Derived Blood-Brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell. 2019;24(6):995\u20131005. e6.","journal-title":"Cell Stem Cell"},{"key":"708_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev-pathol-012414-040418","volume":"10","author":"KH Benam","year":"2015","unstructured":"Benam KH, Dauth S, Hassell B, Herland A, Jain A, Jang KJ, et al. Engineered in vitro disease models. Annu Rev Pathol. 2015;10:195\u2013262.","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"708_CR46","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760\u201372.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"708_CR47","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.stemcr.2018.03.003","volume":"10","author":"PW Brownjohn","year":"2018","unstructured":"Brownjohn PW, Smith J, Solanki R, Lohmann E, Houlden H, Hardy J, et al. Functional studies of missense TREM2 mutations in human stem cell-derived microglia. Stem Cell Reports. 2018;10(4):1294\u2013307.","journal-title":"Stem Cell Reports"},{"issue":"Suppl 1","key":"708_CR48","first-page":"85","volume":"5","author":"RR Butler Iii","year":"2020","unstructured":"Butler Iii RR, Kozlova A, Zhang H, Zhang S, Streit M, Sanders AR, et al. The genetic relevance of human induced pluripotent stem Cell-Derived microglia to alzheimer\u2019s disease and major neuropsychiatric disorders. Mol Neuropsychiatry. 2020;5(Suppl 1):85\u201396.","journal-title":"Mol Neuropsychiatry"},{"issue":"3","key":"708_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12782","volume":"48","author":"C Kurz","year":"2022","unstructured":"Kurz C, Walker L, Rauchmann BS, Perneczky R. Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: evidence from human studies. Neuropathol Appl Neurobiol. 2022;48(3):e12782.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"708_CR50","doi-asserted-by":"publisher","first-page":"e84405","DOI":"10.1371\/journal.pone.0084405","volume":"8","author":"A Karch","year":"2013","unstructured":"Karch A, Manthey H, Ponto C, Hermann P, Heinemann U, Schmidt C, et al. Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia. PLoS ONE. 2013;8(12):e84405.","journal-title":"PLoS ONE"},{"issue":"5","key":"708_CR51","doi-asserted-by":"publisher","first-page":"e10111","DOI":"10.1016\/j.neurobiolaging.2011.10.026","volume":"33","author":"JD Goos","year":"2012","unstructured":"Goos JD, Teunissen CE, Veerhuis R, Verwey NA, Barkhof F, Blankenstein MA, et al. Microbleeds relate to altered amyloid-beta metabolism in alzheimer\u2019s disease. Neurobiol Aging. 2012;33(5):e10111\u20139.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"708_CR52","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.neurobiolaging.2015.05.020","volume":"36","author":"C Chiu","year":"2015","unstructured":"Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD. P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer\u2019s disease: preliminary observations. Neurobiol Aging. 2015;36(9):2475\u201382.","journal-title":"Neurobiol Aging"},{"key":"708_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105441","volume":"124","author":"X Tian","year":"2024","unstructured":"Tian X, Zhao Y, Zhu Y, Cui M. Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: a longitudinal study. Arch Gerontol Geriatr. 2024;124:105441.","journal-title":"Arch Gerontol Geriatr"},{"issue":"6","key":"708_CR54","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/0271678X20952012","volume":"41","author":"WJ Moon","year":"2021","unstructured":"Moon WJ, Lim C, Ha IH, Kim Y, Moon Y, Kim HJ, et al. Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia. J Cereb Blood Flow Metab. 2021;41(6):1351\u201361.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"708_CR55","doi-asserted-by":"publisher","first-page":"e00299","DOI":"10.1016\/j.neurot.2023.10.009","volume":"21","author":"JCS Chaves","year":"2024","unstructured":"Chaves JCS, Wasielewska JM, Cuni-Lopez C, Rantanen LM, Lee S, Koistinaho J, et al. Alzheimer\u2019s disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound. Neurotherapeutics. 2024;21(1):e00299.","journal-title":"Neurotherapeutics"},{"key":"708_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.642812","volume":"12","author":"TM Lu","year":"2021","unstructured":"Lu TM, Barcia Duran JG, Houghton S, Rafii S, Redmond D, Lis R. Human induced pluripotent stem cell-derived brain endothelial cells: current controversies. Front Physiol. 2021;12:642812.","journal-title":"Front Physiol"},{"issue":"16","key":"708_CR57","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.7150\/thno.72685","volume":"12","author":"JM Wasielewska","year":"2022","unstructured":"Wasielewska JM, Chaves JCS, Johnston RL, Milton LA, Hernandez D, Chen L, et al. A sporadic Alzheimer\u2019s blood-brain barrier model for developing ultrasound-mediated delivery of aducanumab and anti-Tau antibodies. Theranostics. 2022;12(16):6826\u201347.","journal-title":"Theranostics"},{"issue":"1","key":"708_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-023-00471-y","volume":"20","author":"U Haferkamp","year":"2023","unstructured":"Haferkamp U, Hartmann C, Abid CL, Brachner A, Hochner A, Gerhartl A, et al. Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease. Fluids Barriers CNS. 2023;20(1):78.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"708_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12987-021-00245-4","volume":"18","author":"Y Ding","year":"2021","unstructured":"Ding Y, Zhong Y, Baldeshwiler A, Abner EL, Bauer B, Hartz AMS. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer\u2019s disease mouse model. Fluids Barriers CNS. 2021;18(1):10.","journal-title":"Fluids Barriers CNS"},{"key":"708_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.05.024","volume":"440","author":"H Rosas-Hernandez","year":"2020","unstructured":"Rosas-Hernandez H, Cuevas E, Raymick JB, Robinson BL, Sarkar S. Impaired amyloid beta clearance and brain microvascular dysfunction are present in the Tg-SwDI mouse model of Alzheimer\u2019s disease. Neuroscience. 2020;440:48\u201355.","journal-title":"Neuroscience"},{"issue":"1","key":"708_CR61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12987-023-00470-z","volume":"20","author":"M Vulin","year":"2023","unstructured":"Vulin M, Zhong Y, Maloney BJ, Bauer B, Hartz AMS. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Abeta brain levels in an alzheimer\u2019s disease model. Fluids Barriers CNS. 2023;20(1):70.","journal-title":"Fluids Barriers CNS"},{"key":"708_CR62","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2018.00186","volume":"10","author":"AMS Hartz","year":"2018","unstructured":"Hartz AMS, Zhong Y, Shen AN, Abner EL, Bauer B. Preventing P-gp ubiquitination lowers Abeta brain levels in an alzheimer\u2019s disease mouse model. Front Aging Neurosci. 2018;10:186.","journal-title":"Front Aging Neurosci"},{"key":"708_CR63","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2017.05.011","volume":"57","author":"D Osgood","year":"2017","unstructured":"Osgood D, Miller MC, Messier AA, Gonzalez L, Silverberg GD. Aging alters mrna expression of amyloid transporter genes at the blood-brain barrier. Neurobiol Aging. 2017;57:178\u201385.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"708_CR64","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","volume":"69","author":"GD Silverberg","year":"2010","unstructured":"Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, et al. Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol. 2010;69(10):1034\u201343.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"708_CR65","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","volume":"30","author":"AL Bartels","year":"2009","unstructured":"Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, et al. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging. 2009;30(11):1818\u201324.","journal-title":"Neurobiol Aging"},{"key":"708_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","volume":"1358","author":"HC Wijesuriya","year":"2010","unstructured":"Wijesuriya HC, Bullock JY, Faull RL, Hladky SB, Barrand MA. ABC efflux transporters in brain vasculature of Alzheimer\u2019s subjects. Brain Res. 2010;1358:228\u201338.","journal-title":"Brain Res"},{"issue":"3","key":"708_CR67","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/cpt.2035","volume":"109","author":"F Storelli","year":"2021","unstructured":"Storelli F, Billington S, Kumar AR, Unadkat JD. Abundance of P-glycoprotein and other drug transporters at the human blood-brain barrier in Alzheimer\u2019s disease: a quantitative targeted proteomic study. Clin Pharmacol Ther. 2021;109(3):667\u201375.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"708_CR68","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","volume":"55","author":"AK Deo","year":"2014","unstructured":"Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B, et al. Activity of P-Glycoprotein, a beta-Amyloid transporter at the Blood-Brain barrier, is compromised in patients with mild alzheimer disease. J Nucl Med. 2014;55(7):1106\u201311.","journal-title":"J Nucl Med"},{"issue":"1","key":"708_CR69","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41467-020-15120-3","volume":"11","author":"SS Kwak","year":"2020","unstructured":"Kwak SS, Washicosky KJ, Brand E, von Maydell D, Aronson J, Kim S, et al. Amyloid-beta42\/40 ratio drives Tau pathology in 3D human neural cell culture models of alzheimer\u2019s disease. Nat Commun. 2020;11(1):1377.","journal-title":"Nat Commun"},{"key":"708_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2020.107318","volume":"175","author":"RJM Riemens","year":"2020","unstructured":"Riemens RJM, Kenis G, van den Beucken T. Human-induced pluripotent stem cells as a model for studying sporadic alzheimer\u2019s disease. Neurobiol Learn Mem. 2020;175:107318.","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"708_CR71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(1):32.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"708_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0317-z","volume":"9","author":"A Ochalek","year":"2017","unstructured":"Ochalek A, Mihalik B, Avci HX, Chandrasekaran A, Teglasi A, Bock I, et al. Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation. Alzheimers Res Ther. 2017;9(1):90.","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"708_CR73","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/jnen\/nlae053","volume":"83","author":"DH Oakley","year":"2024","unstructured":"Oakley DH, Chung M, Abrha S, Hyman BT, Frosch MP. Beta-Amyloid species production and Tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains. J Neuropathol Exp Neurol. 2024;83(9):772\u201382.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"708_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14336\/AD.2017.0112","volume":"8","author":"DL Castillo-Carranza","year":"2017","unstructured":"Castillo-Carranza DL, Nilson AN, Van Skike CE, Jahrling JB, Patel K, Garach P, et al. Cerebral microvascular accumulation of tau oligomers in Alzheimer\u2019s disease and related tauopathies. Aging Dis. 2017;8(3):257\u201366.","journal-title":"Aging Dis"},{"issue":"5","key":"708_CR75","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/0271678X231216144","volume":"44","author":"H Lee","year":"2024","unstructured":"Lee H, Fu JF, Gaudet K, Bryant AG, Price JC, Bennett RE, et al. Aberrant vascular architecture in the hippocampus correlates with Tau burden in mild cognitive impairment and Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2024;44(5):787\u2013800.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"708_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70077","volume":"21","author":"R Guzman-Hernandez","year":"2025","unstructured":"Guzman-Hernandez R, Fossati S. Fibrillar tau alters cerebral endothelial cell metabolism, vascular inflammatory activation, and barrier function in vitro and in vivo. Alzheimers Dement. 2025;21(3):e70077.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"708_CR77","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/s41467-023-37840-y","volume":"14","author":"SA Hussong","year":"2023","unstructured":"Hussong SA, Banh AQ, Van Skike CE, Dorigatti AO, Hernandez SF, Hart MJ, et al. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun. 2023;14(1):2367.","journal-title":"Nat Commun"},{"issue":"5","key":"708_CR78","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","volume":"25","author":"SM Stamatovic","year":"2005","unstructured":"Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab. 2005;25(5):593\u2013606.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"708_CR79","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00018-013-1459-1","volume":"71","author":"Y Yao","year":"2014","unstructured":"Yao Y, Tsirka SE. Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci. 2014;71(4):683\u201397.","journal-title":"Cell Mol Life Sci"},{"key":"708_CR80","doi-asserted-by":"publisher","first-page":"1013933","DOI":"10.3389\/fnmol.2022.1013933","volume":"15","author":"J Yang","year":"2022","unstructured":"Yang J, Ran M, Li H, Lin Y, Ma K, Yang Y, et al. New insight into neurological degeneration: inflammatory cytokines and blood-brain barrier. Front Mol Neurosci. 2022;15:1013933.","journal-title":"Front Mol Neurosci"},{"issue":"7806","key":"708_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"12","key":"708_CR82","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.1002\/alz.14302","volume":"20","author":"ET Reas","year":"2024","unstructured":"Reas ET, Solders SK, Tsiknia A, Triebswetter C, Shen Q, Rivera CS, et al. APOE ?4-related blood-brain barrier breakdown is associated with microstructural abnormalities. Alzheimers Dement. 2024;20(12):8615\u201324.","journal-title":"Alzheimers Dement"},{"key":"708_CR83","doi-asserted-by":"crossref","unstructured":"Uchida Y, Kan H, Sakurai K, Horimoto Y, Hayashi E, Iida A, et al. APOE varepsilon4 dose associates with increased brain iron and beta-amyloid via blood-brain barrier dysfunction. J Neurol Neurosurg Psychiatry. 2022.","DOI":"10.1136\/jnnp-2021-328519"},{"issue":"1","key":"708_CR84","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","volume":"36","author":"MR Halliday","year":"2016","unstructured":"Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, et al. Accelerated pericyte degeneration and blood-brain barrier breakdown in Apolipoprotein E4 carriers with Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2016;36(1):216\u201327.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"708_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14556","volume":"21","author":"A Padovani","year":"2025","unstructured":"Padovani A, Galli A, Bazzoli E, Tolassi C, Caratozzolo S, Gumina B, et al. The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer\u2019s disease. Alzheimers Dement. 2025;21(2):e14556.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"708_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-024-01731-0","volume":"12","author":"AC Raulin","year":"2024","unstructured":"Raulin AC, Doss SV, Heckman MG, Craver EC, Li Z, Ikezu TC, et al. Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer\u2019s disease. Acta Neuropathol Commun. 2024;12(1):25.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"708_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00590-4","volume":"18","author":"CB Young","year":"2023","unstructured":"Young CB, Johns E, Kennedy G, Belloy ME, Insel PS, Greicius MD, et al. APOE effects on regional tau in preclinical Alzheimer\u2019s disease. Mol Neurodegener. 2023;18(1):1.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"708_CR88","doi-asserted-by":"publisher","first-page":"180177","DOI":"10.1098\/rsob.180177","volume":"9","author":"YY Wu","year":"2019","unstructured":"Wu YY, Chiu FL, Yeh CS, Kuo HC. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease. Open Biol. 2019;9(1):180177.","journal-title":"Open Biol"},{"issue":"3","key":"708_CR89","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-020-00796-z","volume":"24","author":"SR Guttikonda","year":"2021","unstructured":"Guttikonda SR, Sikkema L, Tchieu J, Saurat N, Walsh RM, Harschnitz O, et al. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer\u2019s disease. Nat Neurosci. 2021;24(3):343\u201354.","journal-title":"Nat Neurosci"},{"issue":"1","key":"708_CR90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","volume":"25","author":"J Penney","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatry. 2020;25(1):148\u201367.","journal-title":"Mol Psychiatry"},{"issue":"32","key":"708_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403892","volume":"11","author":"FM Pramotton","year":"2024","unstructured":"Pramotton FM, Spitz S, Kamm RD. Challenges and future perspectives in modeling neurodegenerative diseases using organ-on-a-chip technology. Adv Sci. 2024;11(32):e2403892.","journal-title":"Adv Sci"},{"issue":"8","key":"708_CR92","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.molmed.2016.05.010","volume":"22","author":"C Soria-Valles","year":"2016","unstructured":"Soria-Valles C, Lopez-Otin C, iPSCs. On the road to reprogramming aging. Trends Mol Med. 2016;22(8):713\u201324.","journal-title":"Trends Mol Med"},{"issue":"9","key":"708_CR93","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.stem.2021.04.004","volume":"28","author":"J Mertens","year":"2021","unstructured":"Mertens J, Herdy JR, Traxler L, Schafer ST, Schlachetzki JCM, Bohnke L, et al. Age-dependent instability of mature neuronal fate in induced neurons from alzheimer\u2019s patients. Cell Stem Cell. 2021;28(9):1533\u201348. e6.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"708_CR94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.14040","volume":"142","author":"R Patel","year":"2017","unstructured":"Patel R, Page S, Al-Ahmad AJ. Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality. J Neurochem. 2017;142(1):74\u201388.","journal-title":"J Neurochem"},{"issue":"4","key":"708_CR95","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41380-022-01866-3","volume":"28","author":"JW Brunner","year":"2023","unstructured":"Brunner JW, Lammertse HCA, van Berkel AA, Koopmans F, Li KW, Smit AB, et al. Power and optimal study design in iPSC-based brain disease modelling. Mol Psychiatry. 2023;28(4):1545\u201356.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"708_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110643","volume":"39","author":"CY Huang","year":"2022","unstructured":"Huang CY, Nicholson MW, Wang JY, Ting CY, Tsai MH, Cheng YC, et al. Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons. Cell Rep. 2022;39(1):110643.","journal-title":"Cell Rep"},{"issue":"1","key":"708_CR97","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1038\/s41467-023-38704-1","volume":"14","author":"DR Neavin","year":"2023","unstructured":"Neavin DR, Steinmann AM, Farbehi N, Chiu HS, Daniszewski MS, Arora H, et al. A village in a dish model system for population-scale HiPSC studies. Nat Commun. 2023;14(1):3240.","journal-title":"Nat Commun"},{"issue":"8019","key":"708_CR98","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-024-07578-8","volume":"631","author":"N Anton-Bolanos","year":"2024","unstructured":"Anton-Bolanos N, Faravelli I, Faits T, Andreadis S, Kastli R, Trattaro S, et al. Brain chimeroids reveal individual susceptibility to neurotoxic triggers. Nature. 2024;631(8019):142\u20139.","journal-title":"Nature"},{"issue":"2","key":"708_CR99","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41592-024-02555-5","volume":"22","author":"N Caporale","year":"2025","unstructured":"Caporale N, Castaldi D, Rigoli MT, Cheroni C, Valenti A, Stucchi S, et al. Multiplexing cortical brain organoids for the longitudinal dissection of developmental traits at single-cell resolution. Nat Methods. 2025;22(2):358\u201370.","journal-title":"Nat Methods"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00708-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:02:35Z","timestamp":1767704555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00708-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00708-y","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}